Question 1

What is the life expectancy of someone with Cloves Syndrome?

Accepted Answer

CLOVES syndrome is a rare overgrowth condition, and while there is no single fixed life expectancy, the prognosis varies significantly based on the severity of vascular malformations and associated complications. With proactive, multidisciplinary care, many individuals with CLOVES syndrome are living into adulthood and leading meaningful lives, though regular monitoring for progressive symptoms is essential.

How does CLOVES syndrome affect long-term prognosis?
The clinical course of CLOVES syndrome is highly variable, as the condition involves a spectrum of tissue overgrowth and vascular anomalies. Life expectancy is primarily influenced by the complexity of these malformations, particularly those affecting the spine, chest, or deep venous systems. Because CLOVES syndrome is a mosaic condition—meaning it arises from a post-zygotic mutation—the distribution and intensity of symptoms differ for every patient, making it difficult to define a uniform life expectancy.

What factors influence health outcomes in CLOVES syndrome?
Management of CLOVES syndrome requires a team of specialists to address the following critical factors that impact long-term health:

Vascular Complications: Managing the risk of deep vein thrombosis and pulmonary embolism is a priority for many patients.
    Skeletal and Spinal Integrity: Progressive scoliosis or bony overgrowth may require orthopedic intervention to maintain mobility.
    Targeted Pharmacotherapy: The use of PI3K inhibitors has revolutionized the management of CLOVES syndrome, significantly reducing the burden of overgrowth and improving quality of life.
    Systemic Involvement: Regular screening for cardiac or lymphatic issues helps mitigate secondary health risks.

Why is early intervention important for CLOVES syndrome?
Early diagnosis of CLOVES syndrome allows for the implementation of comprehensive care plans before complications become advanced. Advances in molecular diagnostics have enabled clinicians to better understand the PIK3CA-related overgrowth spectrum, leading to more personalized treatment pathways. While CLOVES syndrome remains a life-long journey, the shift toward precision medicine has greatly improved outcomes compared to previous decades, placing a greater emphasis on functional independence and quality of life.

Next steps

Consult with a multidisciplinary team, including specialists in vascular anomalies, genetics, and orthopedics.
    Join the DiseaseMaps.org community to connect with the 7 members who share experiences living with CLOVES syndrome.
    Ask your physician about the latest clinical trials involving PI3K inhibitor therapies.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

National Institutes of Health (NIH) Genetic and Rare Diseases (GARD) Information Center.
    Orphanet: Portal for rare diseases and orphan drugs.
    OMIM (Online Mendelian Inheritance in Man): Entry #612918.
    The CLOVES Syndrome Community (patient advocacy foundation).

Question 2

Celebrities with Cloves Syndrome

Accepted Answer

Currently, there are no globally recognized public figures or celebrities who have publicly disclosed a diagnosis of CLOVES syndrome. While the condition remains rare, affecting an estimated few hundred individuals worldwide, the lack of famous faces has not hindered the dedicated advocacy efforts of the patient community and medical researchers working to increase awareness of this complex overgrowth disorder.

Why is public awareness for CLOVES syndrome important?
Because CLOVES syndrome is an ultra-rare condition—characterized by Congenital Lipomatous Overgrowth, Vascular malformations, Epidermal nevi, and Spinal/Skeletal anomalies—it is often misdiagnosed. When individuals or families share their stories, they help educate the medical community, reducing the time to diagnosis. At DiseaseMaps.org, 7 community members have shared their personal experiences, providing essential peer-to-peer knowledge that formal medical literature sometimes overlooks.

How do advocates champion the cause of CLOVES syndrome?
In the absence of celebrity disclosure, the burden of advocacy falls on patients, families, and specialized clinicians. These groups have been instrumental in securing funding for research into PIK3CA-related overgrowth spectrum (PROS), the genetic family to which CLOVES syndrome belongs. Notable impacts of these advocacy efforts include:

Increased enrollment in clinical trials for PI3K inhibitors.
    Development of specialized multidisciplinary clinics for complex vascular anomalies.
    Enhanced collaboration between geneticists and orthopedic surgeons to manage physical symptoms.
    Creation of dedicated patient-led organizations that provide emotional support and navigate insurance hurdles.

What organizations support those with CLOVES syndrome?
Several organizations focus specifically on providing resources, hosting conferences, and funding research for the CLOVES syndrome community. These groups serve as the primary bridge between families and the latest scientific breakthroughs:

CLOVES Syndrome Community (CSC): The leading patient-led non-profit providing support and advocacy.
    The PROS Network: An international collaboration aimed at improving the lives of those with PIK3CA-related conditions.
    National Organization for Rare Disorders (NORD): Offers resources for rare disease patients to connect with clinical experts.

Next steps

Connect with the 7 members at DiseaseMaps.org to share your journey.
    Visit the CLOVES Syndrome Community website for the latest updates on medical research.
    Consult with a geneticist or a specialist in vascular anomalies to discuss current management strategies.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult a qualified healthcare provider for diagnosis and treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
    Orphanet: Rare disease database entry for CLOVES syndrome.
    OMIM (Online Mendelian Inheritance in Man): Clinical synopsis of PIK3CA-related disorders.
    CLOVES Syndrome Community: Official patient support and research advocacy organization.

Question 3

Is Cloves Syndrome hereditary?

Accepted Answer

CLOVES syndrome is a genetic condition caused by a post-zygotic somatic mutation, meaning it is not hereditary and cannot be passed from parent to child. Because the mutation occurs after conception in a developing embryo, it is considered a sporadic, de novo event rather than an inherited disorder.

Is CLOVES syndrome hereditary?
CLOVES syndrome is not hereditary. It is caused by somatic mosaic mutations in the PIK3CA gene. Unlike inherited conditions that are present in every cell of the body from conception, the genetic changes associated with CLOVES syndrome occur spontaneously during early fetal development. This means that only a fraction of the body’s cells carry the mutation, a state known as mosaicism.

How does the PIK3CA mutation occur?
The PIK3CA-related overgrowth spectrum (PROS), which includes CLOVES syndrome, results from a de novo (new) mutation. Because these mutations occur in somatic cells (non-reproductive cells) after fertilization, they are not present in the sperm or egg cells of the parents. Consequently, there is no increased risk of having another child with CLOVES syndrome in future pregnancies.

What is the role of genetic testing?
Genetic testing is essential for confirming a diagnosis of CLOVES syndrome. Because the mutation is mosaic, standard blood tests may sometimes miss the genetic variant. To ensure accuracy, clinicians often recommend the following:

Tissue-specific testing: Analyzing DNA extracted directly from affected skin or tissue biopsies.
    Deep sequencing: Using high-coverage sequencing techniques to detect low-level mosaicism that standard tests might overlook.
    Clinical correlation: Matching molecular findings with the characteristic features of CLOVES syndrome, such as asymmetric lipomatous overgrowth and vascular malformations.

Why is genetic counseling recommended?
Genetic counseling is vital for families navigating a CLOVES syndrome diagnosis. A counselor can help explain the mechanism of somatic mosaicism, alleviating concerns regarding recurrence risks. While there is no carrier testing for parents—because the condition is not inherited—counseling provides a supportive space to discuss the complexities of managing a rare, multisystemic condition like CLOVES syndrome.

Next steps

Consult with a clinical geneticist experienced in the PIK3CA-related overgrowth spectrum.
    Connect with the 7 members of the DiseaseMaps.org community who are living with CLOVES syndrome to share experiences.
    Request a referral to a multidisciplinary center of excellence for specialized care of CLOVES syndrome.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome.
    Orphanet: PIK3CA-related overgrowth spectrum.
    OMIM (Online Mendelian Inheritance in Man): PIK3CA-related overgrowth spectrum; PROS.
    CLOVES Syndrome Community: Patient resources and research updates.

Question 4

Is Cloves Syndrome contagious?

Accepted Answer

CLOVES syndrome is not contagious; it is a rare, non-communicable genetic condition caused by a somatic mutation. You cannot catch CLOVES syndrome through touch, proximity, or any form of social interaction, as it originates from a change in the DNA within the individual's own body cells.

Is CLOVES syndrome contagious?
No, there is absolutely no risk of contagion associated with CLOVES syndrome. Because this condition is caused by a post-zygotic mutation in the PIK3CA gene, it is not an infectious disease. It cannot be spread through bodily fluids, physical contact, or environmental exposure. Living with, hugging, or caring for someone with CLOVES syndrome presents zero risk of transmission to others.

What is the actual cause of CLOVES syndrome?
CLOVES syndrome is caused by a somatic activating mutation in the PIK3CA gene. Unlike inherited genetic conditions, these mutations occur randomly after conception in a small number of cells. This results in mosaicism, meaning the individual has a mix of cells with and without the mutation. This genetic error leads to the overgrowth of tissues, including fat, bone, and blood vessels, which characterizes CLOVES syndrome.

Why is there confusion regarding contagion?
The visible physical manifestations of CLOVES syndrome, such as lipomatous overgrowth, vascular malformations, and skeletal irregularities, may be misunderstood by those unfamiliar with the condition. Because these physical differences are present from birth or early childhood, some may mistakenly assume the condition is an infection or a contagious skin disease. However, these are strictly developmental anomalies, not markers of an infectious process.

Are there environmental triggers for this condition?
There are no known environmental triggers that cause CLOVES syndrome. It is not linked to diet, lifestyle, or exposure to external pathogens. The condition is strictly the result of a spontaneous genetic event during fetal development.

Common myths and facts about CLOVES syndrome

Myth: It can be passed to siblings or classmates. Fact: It is not inherited and cannot be transmitted.
    Myth: It is caused by an underlying infection. Fact: It is a developmental disorder of the PIK3CA pathway.
    Fact: Seven members of the DiseaseMaps.org community living with CLOVES syndrome confirm that their condition has no impact on the health of those around them.

Next steps

Consult a geneticist or a specialist in vascular anomalies to understand the specific PIK3CA mutation.
    Connect with the CLOVES syndrome community at DiseaseMaps.org to share experiences and receive peer support.
    Educate family and friends by sharing verified resources from the NIH GARD to dispel myths about the condition.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome profile.
    Orphanet: Rare disease overview for CLOVES syndrome (ORPHA: 261159).
    OMIM (Online Mendelian Inheritance in Man): PIK3CA-Related Overgrowth Spectrum (PROS).
    CLOVES Syndrome Community: Official patient advocacy and support resources.

Question 5

ICD10 code of Cloves Syndrome and ICD9 code

Accepted Answer

CLOVES syndrome does not have a unique, dedicated code in the ICD-9 or ICD-10 systems, as it is a rare overgrowth disorder often categorized under broader classifications for congenital malformations or vascular anomalies. Clinicians typically use ICD-10 code Q87.3 (Congenital malformation syndromes involving overgrowth) or Q27.8 (Other specified congenital malformations of peripheral vascular system) to document and bill for CLOVES syndrome.

What exactly is CLOVES syndrome?
CLOVES syndrome is a rare, complex disorder characterized by Congenital Lipomatous Overgrowth, Vascular malformations, Epidermal nevi, and Spinal/Skeletal anomalies. Because CLOVES syndrome is caused by somatic mosaic mutations in the PIK3CA gene, it presents with a highly variable clinical phenotype, which makes standardized medical coding challenging for healthcare providers.

How is CLOVES syndrome diagnosed and managed?
Diagnosis of CLOVES syndrome is primarily clinical, supported by targeted genetic testing of affected tissue. Management requires a multidisciplinary team approach to address the specific needs of each patient. Common clinical focus areas for those living with CLOVES syndrome include:

Surgical management: Debulking of fatty overgrowth and correction of skeletal deformities.
    Vascular intervention: Sclerotherapy or embolization to manage complex vascular malformations.
    Pharmacological therapy: Use of PI3K inhibitors (such as alpelisib) to target the underlying molecular pathway.
    Orthopedic support: Monitoring for scoliosis and limb length discrepancies.

Is there a community for those affected by CLOVES syndrome?
Navigating the diagnostic journey of CLOVES syndrome can feel isolating, but you are not alone. Currently, 7 people with CLOVES syndrome have joined the DiseaseMaps.org community to share their experiences, provide peer support, and exchange information on managing the daily challenges of this condition.

Next steps

Consult with a geneticist or a specialist in vascular anomalies to confirm a diagnosis of CLOVES syndrome.
    Connect with the 7 members of the CLOVES syndrome community on DiseaseMaps.org for lived-experience insights.
    Request a referral to a center of excellence that specializes in PIK3CA-related overgrowth spectrum (PROS) disorders.

Medical disclaimer: This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding any medical condition.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome entry.
    Orphanet: Rare disease database entry for CLOVES syndrome.
    OMIM (Online Mendelian Inheritance in Man): #612918 (CLOVES Syndrome).
    The CLOVES Syndrome Community (patient advocacy organization).

Question 6

Is there any natural treatment for Cloves Syndrome?

Accepted Answer

There is currently no scientifically proven natural treatment or herbal remedy that can cure or alter the underlying genetic cause of CLOVES syndrome. While complementary practices may help manage secondary symptoms like pain or mobility issues, they must always be used as an adjunct to, and never a replacement for, clinical care overseen by your specialist team.

Are there natural remedies for CLOVES syndrome?
There is no clinical evidence supporting the use of herbal supplements or natural cures for CLOVES syndrome, a rare overgrowth disorder caused by somatic mutations in the PIK3CA gene. Because CLOVES syndrome involves complex vascular malformations and tissue overgrowth, systemic herbal "detoxes" or supplements have no mechanism to address these structural anomalies and could potentially interfere with targeted therapies like PI3K inhibitors.

What supportive therapies are commonly used for CLOVES syndrome?
Many patients in the DiseaseMaps.org community, where 7 members have shared their experiences, focus on physical and lifestyle-based management to maintain quality of life. These approaches aim to improve comfort rather than treat the genetic condition itself:

Physical Therapy: Essential for managing joint stiffness, improving range of motion, and supporting mobility in limbs affected by overgrowth.
    Compression Garments: Frequently used to manage lymphedema and reduce swelling associated with the vascular malformations common in CLOVES syndrome.
    Mind-Body Practices: Techniques like gentle yoga, meditation, and mindfulness are used by some to manage the chronic pain and psychological stress associated with living with a rare, visible condition.
    Aquatic Therapy: Low-impact movement in water can provide relief for patients with limited mobility or joint pain.

What are the risks of alternative therapies?
When considering any complementary approach for CLOVES syndrome, it is vital to be aware of safety risks. Some herbal supplements can cause blood thinning or liver strain, which is particularly dangerous for patients who may already be at risk of coagulopathy or who are taking specialized pharmacological treatments. Always consult your multidisciplinary team before adding any new supplement to your routine.

Next steps

Consult your multidisciplinary team—including geneticists, vascular specialists, and orthopedic surgeons—before starting any new physical or dietary regimen.
    Connect with the 7 members of our DiseaseMaps.org community to learn what supportive lifestyle strategies have provided them with the most comfort.
    Monitor for any changes in tissue overgrowth or vascular symptoms and report them immediately to your primary care physician.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare provider regarding your specific condition.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
    Orphanet: Rare disease portal for CLOVES syndrome (ORPHA: 209995).
    OMIM (Online Mendelian Inheritance in Man): PIK3CA-related overgrowth spectrum (PROS).
    CLOVES Syndrome Community: Patient-led resources and research updates.

Question 7

Living with Cloves Syndrome. How to live with Cloves Syndrome?

Accepted Answer

Living with CLOVES syndrome requires a multidisciplinary approach that balances complex medical management with proactive mental health support to manage the emotional weight of a rare, progressive condition. By focusing on building a resilient support network and prioritizing quality of life, individuals and families can find meaningful ways to navigate the unique challenges posed by CLOVES syndrome.

What is the emotional impact of CLOVES syndrome?
Receiving a diagnosis of CLOVES syndrome often brings a complex mix of grief, anxiety, and uncertainty. Because CLOVES syndrome involves visible physical differences and potential mobility challenges, many individuals experience social anxiety or feelings of isolation. It is important to validate these feelings; they are a natural response to the chronic stress of managing a rare, multisystem condition that requires frequent medical interventions and monitoring.

How can I build resilience while managing CLOVES syndrome?
Psychological resilience is not about ignoring the difficulties of CLOVES syndrome, but rather learning to adapt and find joy alongside the medical reality. Practical strategies often include:

Adaptive Hobbies: Engaging in activities that accommodate physical limitations, such as swimming or digital art, to maintain a sense of agency.
    Mindfulness-Based Stress Reduction: Utilizing guided meditation to manage chronic pain or anxiety related to medical procedures.
    Radical Acceptance: Working with a therapist to accept the reality of CLOVES syndrome while identifying areas where you still have personal control.

Why is community support vital for CLOVES syndrome patients?
Connecting with others is perhaps the most powerful tool for those affected by CLOVES syndrome. Shared experiences reduce the profound sense of isolation that often accompanies rare diseases. At DiseaseMaps.org, 7 people with CLOVES syndrome have joined the community to share their personal insights, treatment experiences, and emotional support, proving that you do not have to walk this path alone.

When should I seek professional mental health support?
It is advisable to consult a psychologist specializing in chronic illness if you notice persistent feelings of hopelessness, significant changes in sleep or appetite, or if the demands of managing CLOVES syndrome interfere with your ability to enjoy daily life. Early intervention can provide you with the coping tools necessary to maintain your well-being over the long term.

Next steps

Join the DiseaseMaps.org community to connect with the 7 other members living with CLOVES syndrome.
    Consult with a clinical geneticist or a specialist physician at a center experienced in treating overgrowth syndromes.
    Reach out to the CLOVES Syndrome Community foundation for disease-specific resources and advocacy updates.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

NIH Genetic and Rare Diseases Information Center (GARD)
    Orphanet: Rare Disease Database (ORPHA: 209995)
    OMIM (Online Mendelian Inheritance in Man): #612918
    CLOVES Syndrome Community (clovessyndrome.org)

Question 8

Cloves Syndrome diet. Is there a diet which improves the quality of life of people with Cloves Syndrome?

Accepted Answer

Currently, there is no specific, scientifically validated "CLOVES syndrome diet" that can cure or directly treat the underlying PIK3CA-related overgrowth. While dietary modifications cannot alter the genetic mutation driving CLOVES syndrome, maintaining a balanced, anti-inflammatory nutritional approach can help manage secondary symptoms like chronic pain, fatigue, and systemic inflammation.

Are there specific dietary recommendations for CLOVES syndrome?
There is no evidence-based clinical diet for CLOVES syndrome. Because this condition involves complex vascular malformations and tissue overgrowth, medical nutrition therapy is usually focused on general wellness and supporting the body during periods of inflammation or post-surgical recovery. Always consult with a metabolic dietitian or your primary specialist before attempting restrictive diets, especially given the potential for rapid growth and metabolic demands in patients with CLOVES syndrome.

How can nutrition support symptom management?
While evidence is limited, many families within the DiseaseMaps.org community and clinical settings report that focusing on nutrient-dense foods helps with overall energy levels. Consider the following general wellness strategies:

Anti-inflammatory focus: Emphasize whole foods like fatty fish (omega-3s), berries, leafy greens, and nuts to help manage the chronic inflammation often associated with vascular anomalies.
    Hydration: Adequate water intake is essential for lymphatic health, which is frequently compromised in patients with CLOVES syndrome due to lymphatic malformations.
    Balanced Macronutrients: Protein is crucial for tissue repair, particularly for patients undergoing frequent surgeries or dealing with chronic skin breakdown.

What should be avoided in CLOVES syndrome?
There are no specific foods clinically proven to exacerbate CLOVES syndrome. However, processed foods high in refined sugars and trans fats may contribute to systemic inflammation, which can theoretically worsen discomfort in individuals already struggling with vascular or lymphatic malformations. If you are taking PIK3CA inhibitors (such as alpelisib), you must work closely with your physician, as these medications can cause specific side effects like hyperglycemia, requiring strict monitoring of carbohydrate intake.

Next steps

Consult with a registered dietitian who specializes in rare genetic disorders.
    Track your symptoms in a journal to see if specific food groups correlate with increased pain or swelling.
    Join the 7 members of the DiseaseMaps.org community to share experiences on symptom management.
    Discuss any planned supplement use with your geneticist to avoid interactions with current medications.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from your healthcare provider.

References

NIH Genetic and Rare Diseases Information Center (GARD) – CLOVES Syndrome.
    Orphanet: PIK3CA-Related Overgrowth Spectrum (PROS).
    OMIM (Online Mendelian Inheritance in Man): Entry #612918.
    The CLOVES Syndrome Community (patient advocacy and support).

Question 9

What is the history of Cloves Syndrome?

Accepted Answer

CLOVES syndrome was first described in medical literature in 2007 by Dr. Richard J. Sapp and colleagues, who identified it as a distinct overgrowth disorder characterized by a specific constellation of clinical features. The discovery marked a significant pivot from grouping these patients under the umbrella of Proteus syndrome to recognizing CLOVES syndrome as a unique entity driven by distinct genetic mechanisms.

When was CLOVES syndrome first defined?
Before 2007, patients with CLOVES syndrome were often misdiagnosed with Proteus syndrome or Klippel-Trenaunay syndrome. The acronym CLOVES syndrome (Congenital Lipomatous Overgrowth, Vascular malformations, Epidermal nevi, and Spinal/Skeletal anomalies) was coined to provide a clearer diagnostic framework. Researchers realized that these patients lacked the progressive, aggressive bone overgrowth typical of Proteus syndrome, necessitating a separate classification.

How did genetics change our understanding of CLOVES syndrome?
The landscape of CLOVES syndrome research changed dramatically in 2012 when the underlying cause was identified as a somatic activating mutation in the PIK3CA gene. This discovery moved the condition from a mysterious, idiopathic disorder to a well-defined PIK3CA-Related Overgrowth Spectrum (PROS) condition. This genetic clarity has been vital for the 7 people with CLOVES syndrome currently in our DiseaseMaps community to better understand their diagnosis.

What are the major milestones in treatment?
The evolution of treatment for CLOVES syndrome has shifted from purely surgical management to targeted molecular therapy:

Surgical Intervention: Historically, debulking surgeries were the only option for managing lipomatous overgrowth.
    PI3K Inhibitors: The development of alpelisib (a PI3K inhibitor) has revolutionized care, offering a way to target the molecular driver of the overgrowth.
    Multidisciplinary Care: Modern clinical management now emphasizes coordinated care between genetics, dermatology, orthopedic surgery, and interventional radiology.

Next steps

Consult with a clinical geneticist to discuss PIK3CA testing and the latest treatment options.
    Join the CLOVES syndrome community on DiseaseMaps.org to connect with others sharing similar health journeys.
    Review current clinical trials on ClinicalTrials.gov to see if you or your family member are eligible for new therapeutic studies.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
    Orphanet: Rare disease database entry for CLOVES syndrome.
    OMIM (Online Mendelian Inheritance in Man): PIK3CA-related overgrowth spectrum.
    CLOVES Syndrome Community: Patient advocacy and research foundation resources.

Question 10

Is it advisable to do exercise when affected by Cloves Syndrome? Which activities would you suggest and how intense should they be?

Accepted Answer

Yes, exercise is generally recommended and beneficial for individuals with CLOVES syndrome, provided it is approached with caution and tailored to the individual’s specific vascular and orthopedic needs. Gentle, low-impact activity can help maintain joint mobility, improve lymphatic flow, and support cardiovascular health, though it must always be cleared by your multidisciplinary care team.

Is exercise safe for those with CLOVES syndrome?
Because CLOVES syndrome involves complex vascular malformations and potential orthopedic complications, exercise must be approached strategically. Physical activity is not contraindicated, but the intensity and type must be carefully managed to avoid triggering swelling or putting undue stress on affected limbs. For the 7 members of our DiseaseMaps community living with CLOVES syndrome, movement is often a key tool for managing daily comfort and mood.

What types of exercise are recommended?
The goal of exercise for CLOVES syndrome is to improve functional mobility without overexerting the vascular system. Focus on activities that minimize gravity-dependent stress:

Swimming and water aerobics: The hydrostatic pressure of water is excellent for reducing edema and supporting joints.
Stationary cycling: Allows for cardiovascular conditioning while controlling the range of motion.
Restorative yoga or Pilates: Excellent for maintaining flexibility and core strength, provided poses are modified for orthopedic comfort.
Walking on level surfaces: Builds endurance while allowing for immediate rest if fatigue sets in.

How can I start an exercise program safely?
Before beginning, consult with your vascular specialist or orthopedic surgeon to understand the specific limitations of your anatomy. A physical therapist experienced in rare vascular anomalies can develop a personalized plan. Start with a "low and slow" approach: begin with 5–10 minutes of low-intensity movement and monitor for increased swelling or pain for 24 hours before increasing duration.

What is the role of pacing and adaptation?
On "flare" days when CLOVES syndrome causes increased pain or swelling, prioritize rest and elevation over exercise. Pacing is essential; listen to your body’s signals and break activity into short, manageable segments throughout the day rather than one long session.

Next steps

Request a referral to a physical therapist specialized in lymphedema or vascular malformations.
Keep a symptom diary to track how your body responds to specific movements.
Connect with the 7 members at DiseaseMaps.org to share experiences regarding mobility.
Ensure you have medical clearance regarding the use of compression garments during physical activity.

Medical disclaimer: This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment; always consult your physician before starting any new exercise program.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
Orphanet: Rare disease database for CLOVES syndrome.
International Society for the Study of Vascular Anomalies (ISSVA) classification guidelines.
PubMed: Clinical studies on rehabilitation strategies for complex vascular malformations.

Question 11

How is Cloves Syndrome diagnosed?

Accepted Answer

CLOVES syndrome is primarily diagnosed through clinical examination by a specialist and confirmed via molecular genetic testing that identifies a somatic (non-hereditary) activating mutation in the PIK3CA gene. Because CLOVES syndrome is a spectrum disorder with highly variable presentations, diagnosis often requires a multidisciplinary team to evaluate the characteristic pattern of vascular malformations, overgrowth, and spinal anomalies.

How is CLOVES syndrome diagnosed?
The diagnostic process for CLOVES syndrome begins with a physical assessment of the classic features: Congenital Lipomatous Overgrowth, Vascular malformations, Epidermal nevi, and Spinal/Skeletal anomalies. Because these symptoms can mimic other conditions, physicians rely on targeted genetic testing of affected tissue (biopsy) rather than standard blood samples, as the PIK3CA mutation is often mosaic, meaning it is not present in every cell of the body.

What tests are used to identify CLOVES syndrome?
Clinical specialists utilize several diagnostic modalities to confirm a case of CLOVES syndrome:

Genetic Testing: Targeted deep sequencing of affected tissue samples to detect somatic PIK3CA mutations.
    Advanced Imaging: MRI scans are essential to map the extent of vascular malformations and assess spinal alignment.
    Clinical Evaluation: Assessment by genetics, dermatology, and orthopedics to verify the diagnostic criteria.
    Biopsy: Analysis of tissue from overgrowth areas to confirm the genetic driver.

Why is the diagnostic journey so challenging?
Many patients with CLOVES syndrome experience a "diagnostic odyssey," often waiting years for an accurate diagnosis due to the rarity of the condition and its overlap with other PIK3CA-Related Overgrowth Spectrum (PROS) disorders. It is common for CLOVES syndrome to be initially misdiagnosed as Klippel-Trénaunay syndrome or other vascular anomalies. We hear the frustration of our 7 community members at DiseaseMaps.org who have navigated this path; please know that your search for answers is valid and your persistence is vital.

Why is specialist care critical?
Because CLOVES syndrome involves complex multi-system involvement, it is essential to consult with specialists—such as pediatric geneticists or vascular anomaly experts—who are familiar with the PIK3CA spectrum. General practitioners may not recognize the subtle clinical markers, making specialized referral the most effective way to end the diagnostic uncertainty.

Next steps

Consult a center of excellence specializing in vascular anomalies or genetic overgrowth syndromes.
    Request a referral to a clinical geneticist for targeted PIK3CA testing.
    Connect with the 7 members of our CLOVES syndrome community at DiseaseMaps.org to share experiences and provider recommendations.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome
    Orphanet: CLOVES syndrome
    OMIM (Online Mendelian Inheritance in Man): PIK3CA-Related Overgrowth Spectrum
    The CLOVES Syndrome Community (patient advocacy foundation)

Question 12

Which are the symptoms of Cloves Syndrome?

Accepted Answer

CLOVES syndrome is a rare overgrowth disorder characterized by Congenital Lipomatous Overgrowth, Vascular malformations, Epidermal nevi, and Spinal/Skeletal anomalies. Symptoms are highly variable, typically manifesting at birth or in early infancy as asymmetric tissue overgrowth and complex vascular issues that require multidisciplinary clinical management.

What are the primary symptoms of CLOVES syndrome?
The name CLOVES syndrome serves as an acronym for its hallmark clinical features. Patients often present with a combination of the following manifestations:

Congenital Lipomatous Overgrowth: Soft, fatty masses that are typically non-cancerous but can grow rapidly.
    Vascular malformations: Commonly low-flow venous or lymphatic malformations that may cause pain or swelling.
    Epidermal nevi: Skin lesions that are often verrucous (wart-like) and may darken over time.
    Spinal/Skeletal anomalies: Including scoliosis, wide feet, or localized gigantism of digits and limbs.

How do symptoms of CLOVES syndrome vary between patients?
The severity of CLOVES syndrome exists on a broad spectrum. While some individuals may have mild cutaneous findings, others experience significant orthopedic complications or severe vascular malformations that impact mobility. Because CLOVES syndrome is caused by a somatic mutation in the PIK3CA gene, the timing and distribution of the mutation during embryonic development dictate the specific areas and intensity of the overgrowth.

What are the early warning signs and progression?
Early signs often include asymmetric limb size at birth or the presence of soft, doughy masses on the trunk or extremities. As children with CLOVES syndrome grow, the skeletal overgrowth may lead to joint pain, restricted range of motion, or complications from scoliosis. It is critical to monitor for rapid changes in vascular malformations or sudden growth in fatty masses, as these can affect daily quality of life and physical function.

When should I seek immediate medical attention?
Families should seek urgent care if a patient with CLOVES syndrome experiences sudden, intense pain, significant swelling, signs of infection near a vascular malformation, or unexplained neurological symptoms related to spinal involvement. Regular screening with a specialized multidisciplinary team is essential to track the progression of CLOVES syndrome symptoms.

Next steps

Consult with a pediatric geneticist or a vascular anomalies specialist to coordinate multidisciplinary care.
    Connect with the 7 members of the CLOVES syndrome community on DiseaseMaps.org to share experiences and coping strategies.
    Maintain a detailed log of physical changes and symptom progression to share with your care team.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult a qualified healthcare professional regarding any medical condition.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
    Orphanet: Rare disease database entry for CLOVES syndrome.
    OMIM (Online Mendelian Inheritance in Man): PIK3CA-related overgrowth spectrum.
    CLOVES Syndrome Community: Patient resources and educational materials.

Question 13

Can people with Cloves Syndrome work? What kind of work can they perform?

Accepted Answer

Individuals with CLOVES syndrome can and do maintain successful careers, though the ability to work depends heavily on the specific nature and severity of their overgrowth and vascular malformations. Employment feasibility is determined by an individual's physical mobility, the presence of chronic pain, and the need for ongoing medical management, rather than the diagnosis of CLOVES syndrome itself.

What factors influence workplace participation for those with CLOVES syndrome?
Because CLOVES syndrome presents a wide spectrum of symptoms, including lipomatous overgrowth, vascular anomalies, and skeletal deformities, every person’s experience is unique. Many individuals with CLOVES syndrome thrive in professional environments that prioritize output over physical presence. The most significant barriers are often physical fatigue from managing tissue overgrowth or the necessity of frequent clinical appointments for monitoring or surgical interventions.

What types of work are suitable for individuals with CLOVES syndrome?
Work that minimizes prolonged standing or repetitive physical strain is often more sustainable. Many members of the DiseaseMaps community with CLOVES syndrome have found success in roles that offer autonomy and flexibility. Suitable career paths often include:

Knowledge-based roles (software development, data analysis, or writing)
    Creative fields (graphic design or digital media)
    Administrative or project management positions
    Consulting or remote-based educational instruction

How can workplace accommodations support career longevity?
Workplace accommodations are essential tools for managing the health complexities of CLOVES syndrome. Under laws like the ADA (in the U.S.) or similar international legislation, employers are often required to provide reasonable adjustments. Effective accommodations include:

Ergonomic support: Custom seating or standing desks to accommodate limb differences or mobility devices.
    Flexible scheduling: The ability to adjust hours to attend physical therapy or specialized medical appointments.
    Remote work options: Reducing the physical toll of commuting and allowing for a controlled, comfortable environment.
    Task modification: Adjusting physical requirements to focus on core competencies.

How should one approach employer communication?
When discussing CLOVES syndrome with an employer, focus on your professional value and the specific, simple modifications that allow you to perform your best. Frame the conversation around productivity and partnership rather than illness. Providing clear, concise documentation from your medical team regarding your functional needs can help demystify the condition and establish a supportive professional relationship.

Next steps

Consult with an occupational therapist to identify ergonomic needs specific to your CLOVES syndrome symptoms.
    Connect with the 7 members of the DiseaseMaps community who share experiences with CLOVES syndrome for peer support.
    Review local disability rights resources to understand your legal protections regarding workplace accommodations.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases (GARD) Information Center: CLOVES syndrome overview.
    Orphanet: Rare disease database entry for CLOVES syndrome.
    OMIM (Online Mendelian Inheritance in Man): Clinical features and genetic basis of CLOVES syndrome.
    CLOVES Syndrome Community: Patient advocacy and support resources.

Question 14

How do I know if I have Cloves Syndrome?

Accepted Answer

CLOVES syndrome is a rare overgrowth disorder characterized by Congenital Lipomatous Overgrowth, Vascular malformations, Epidermal nevi, and Spinal/Skeletal anomalies. Diagnosis is primarily confirmed through clinical evaluation by a specialist and genetic testing to identify a somatic mutation in the PIK3CA gene, which is not inherited from parents but occurs spontaneously after conception.

What are the early signs and symptoms of CLOVES syndrome?
The name CLOVES syndrome serves as an acronym for the primary clinical features. Individuals often present at birth or in early infancy with soft, fatty masses (lipomatous overgrowth), typically on the trunk or limbs. Vascular malformations, such as port-wine stains or venous malformations, are common, alongside epidermal nevi (skin lesions) and specific skeletal variations like large feet or hands (macrodactyly) and spinal curvature (scoliosis).

How is CLOVES syndrome diagnosed?
Diagnosis is a process of clinical observation followed by molecular confirmation. Because CLOVES syndrome is caused by a mosaic PIK3CA mutation, a standard blood test may not always detect it; doctors often prefer to biopsy the affected tissue. Key diagnostic steps include:

Physical examination by a clinical geneticist or pediatric dermatologist.
    MRI or CT imaging to assess the extent of vascular and fatty tissue involvement.
    Genetic sequencing of affected tissue samples to identify the PIK3CA mutation.
    Orthopedic evaluation to monitor spinal and limb development.

When should I seek urgent medical evaluation?
While CLOVES syndrome is a chronic condition, certain "red flags" require prompt attention. Seek immediate care if you notice rapid, painful enlargement of a fatty mass, sudden onset of severe pain, signs of deep vein thrombosis (DVT) in affected limbs, or neurological changes such as weakness or numbness that could indicate spinal cord involvement.

How can I advocate for myself with medical professionals?
If you suspect you or a loved one has CLOVES syndrome, it is essential to be your own best advocate. Because the condition is rare, many general practitioners may not be familiar with it. When speaking to your doctor, bring printed literature from reputable sources like the NIH GARD or DiseaseMaps.org, where 7 community members have shared their experiences. If your concerns are dismissed, request a referral to a center specializing in vascular anomalies or a pediatric genetics department.

Next steps

Consult a clinical geneticist or a vascular anomalies specialist.
    Request a referral for genetic testing targeting the PIK3CA pathway.
    Join a patient support community, such as the group at DiseaseMaps.org, to connect with others navigating CLOVES syndrome.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
    Orphanet: Rare disease database entry for CLOVES syndrome.
    OMIM (Online Mendelian Inheritance in Man): PIK3CA-related overgrowth spectrum.
    CLOVES Syndrome Community: Patient-led advocacy and support resources.

Question 15

What are the best treatments for Cloves Syndrome?

Accepted Answer

CLOVES syndrome treatment is highly personalized, focusing on managing complex overgrowth, vascular malformations, and potential complications through a combination of targeted systemic therapy and surgical intervention. Management is best coordinated by a multidisciplinary team to address the specific, evolving clinical needs of each individual patient.

What are the primary medical treatments for CLOVES syndrome?
The standard of care for CLOVES syndrome has shifted significantly with the use of PI3K inhibitors. Sirolimus (Rapamune) has historically been used to manage vascular malformations and overgrowth, but Alpelisib (Piqray) is increasingly utilized as a targeted therapy to inhibit the PI3K pathway directly. Because CLOVES syndrome is caused by somatic mutations in the PIK3CA gene, these medications aim to reduce the size of vascular lesions and manage the progressive overgrowth associated with the condition.

What non-pharmacological and surgical options exist?
Surgical management for CLOVES syndrome is complex and typically reserved for functional impairment or severe pain. Multidisciplinary care often includes:

Orthopedic surgery: To address progressive scoliosis or limb length discrepancies.
    Interventional radiology: Sclerotherapy to shrink complex lymphatic or venous malformations.
    Physical and Occupational Therapy: Essential for maintaining mobility and managing lymphedema.
    Compression garments: Often used to manage swelling and support affected limbs.

Which specialists should be on the care team?
Due to the multisystem nature of CLOVES syndrome, care must be managed by a team of experts. Recommended specialists typically include a pediatric geneticist, a vascular anomalies specialist, an orthopedic surgeon, a dermatologist, and a physical therapist. At DiseaseMaps.org, our community of 7 members highlights the value of sharing experiences with these multidisciplinary teams to navigate the complexities of CLOVES syndrome.

What is the outlook for emerging research?
Clinical research into CLOVES syndrome is rapidly evolving. Current clinical trials are focusing on the long-term safety and efficacy of PI3K inhibitors in pediatric populations. Treatment effectiveness varies greatly between patients depending on the specific location and severity of the overgrowth, requiring frequent reassessment by your clinical team.

Next steps

Consult with a specialized center for vascular anomalies or a pediatric genetics department.
    Join the DiseaseMaps community to connect with other families living with CLOVES syndrome.
    Maintain a detailed log of symptoms and treatment responses to assist your multidisciplinary care team.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; all treatment decisions must be made in consultation with your personal healthcare team.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome
    Orphanet: CLOVES syndrome (ORPHA:261244)
    OMIM (Online Mendelian Inheritance in Man): PIK3CA-Related Overgrowth Spectrum
    The CLOVES Syndrome Community (patient advocacy organization)

Question 16

What is the prevalence of Cloves Syndrome?

Accepted Answer

CLOVES syndrome is an ultra-rare disorder characterized by Congenital Lipomatous Overgrowth, Vascular malformations, Epidermal nevi, and Spinal/Skeletal anomalies. While precise global prevalence is unknown, it is estimated to affect fewer than 200 individuals worldwide, though this figure is likely an underestimation due to historical misdiagnosis.

How common is CLOVES syndrome?
Because CLOVES syndrome is an ultra-rare condition, population-based epidemiological studies are limited. The disorder is caused by somatic mosaic mutations in the PIK3CA gene, meaning it is not inherited from parents but occurs post-conception. Because it is not a hereditary condition, there is no predictable incidence rate per birth. The current clinical consensus classifies CLOVES syndrome as ultra-rare, with only a small number of confirmed cases documented in medical literature.

What challenges exist in tracking CLOVES syndrome prevalence?
Accurate data collection for CLOVES syndrome is hindered by several factors:

Diagnostic Complexity: Patients are frequently misdiagnosed with other overgrowth syndromes, such as Proteus syndrome or Klippel-Trenaunay syndrome, before receiving a correct diagnosis.
    Phenotypic Variability: The severity of CLOVES syndrome varies significantly, leading to potential under-reporting of milder cases.
    Lack of Centralized Registries: Because the condition is so rare, global patient registries are still in development.

Are there demographic patterns in CLOVES syndrome?
Current clinical data indicates that CLOVES syndrome affects males and females equally. While the condition is typically identified at birth due to visible physical features, the age of diagnosis can vary depending on the severity of internal vascular or spinal manifestations. There is no evidence suggesting that CLOVES syndrome is more prevalent in any specific geographic region or ethnic group.

How does the DiseaseMaps community reflect these statistics?
At DiseaseMaps.org, we have 7 individuals currently sharing their journey with CLOVES syndrome. While this is a small sample, it underscores the rarity of the condition and provides a vital platform for families to connect, exchange information, and contribute to a better understanding of the patient experience outside of traditional clinical settings.

Next steps

Consult with a geneticist or a specialist in vascular anomalies to confirm a diagnosis through molecular testing.
    Join the DiseaseMaps.org community to connect with other families living with this rare condition.
    Discuss the potential for targeted therapy, such as PI3K inhibitors, with your medical team.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES Syndrome.
    Orphanet: Rare Disease Database (ORPHA: 261245).
    OMIM (Online Mendelian Inheritance in Man): Entry #612918.
    The CLOVES Syndrome Community (patient foundation resource).

Question 17

Cloves Syndrome and depression

Accepted Answer

CLOVES syndrome is a rare overgrowth disorder that can significantly impact mental health due to chronic pain, physical disability, and the visible nature of the condition. While there is no direct biochemical link between the PIK3CA gene mutation and depression, the psychosocial burden of managing CLOVES syndrome frequently leads to increased rates of anxiety, depression, and social isolation.

What is the psychological impact of living with CLOVES syndrome?
Living with CLOVES syndrome involves navigating complex medical treatments and potential physical differences. Patients often face challenges related to body image, the stress of frequent hospitalizations, and the limitations imposed by vascular malformations. At DiseaseMaps.org, 7 members have connected to share these experiences, highlighting that the emotional toll of CLOVES syndrome is often as significant as the physical symptoms.

How do chronic pain and disability affect mental health in CLOVES syndrome?
Chronic pain and fatigue associated with CLOVES syndrome are major contributors to mood disorders. The physical requirements of managing CLOVES syndrome can lead to a sense of loss of control. Common challenges include:

Social Isolation: Difficulty participating in peer activities due to physical limitations.
Body Image Concerns: Navigating the visibility of tissue overgrowth.
Medical Trauma: Stress resulting from repeated surgeries or complex procedures.
Caregiver Burnout: The emotional strain on families supporting a loved one with CLOVES syndrome.

How can patients manage depression and anxiety?
Effective management of the mental health aspects of CLOVES syndrome involves a multidisciplinary approach. Therapies such as Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) are highly effective for chronic illness adaptation. If you or a loved one notice persistent sadness, loss of interest, or changes in sleep, seek professional support. If you are experiencing suicidal thoughts, please call or text 988 in the US or contact local emergency services immediately.

Next steps

Consult with a specialized psychologist who has experience with chronic or visible illnesses.
Join the CLOVES syndrome community at DiseaseMaps.org to connect with others who truly understand your journey.
Discuss mental health screenings with your primary care physician or pediatric specialist.
Focus on building a support network that includes both medical professionals and peer advocates.

Medical disclaimer: This content is for informational purposes only and does not substitute professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
Orphanet: Rare disease database entry for CLOVES syndrome.
OMIM (Online Mendelian Inheritance in Man): PIK3CA-related overgrowth spectrum.
CLOVES Syndrome Community: Patient advocacy and support resources.

Question 18

Which are the causes of Cloves Syndrome?

Accepted Answer

CLOVES syndrome is caused by post-zygotic somatic gain-of-function mutations in the PIK3CA gene, which occur after conception rather than being inherited from parents. These mutations trigger the overactivation of the PI3K/AKT/mTOR signaling pathway, leading to the characteristic overgrowth of fatty tissues, blood vessels, and skeletal structures seen in patients.

What causes CLOVES syndrome at the genetic level?
The primary cause of CLOVES syndrome is a sporadic mutation in the PIK3CA gene. Unlike many genetic conditions, this mutation is not passed down from parents; it occurs randomly in a single cell during early embryonic development. Because this is a somatic mosaic condition, only a portion of the body's cells carry the mutation, while others remain genetically normal. This explains why the clinical presentation of CLOVES syndrome varies so significantly between different individuals.

How does the PIK3CA mutation affect the body?
The PIK3CA gene provides instructions for making a protein that acts like a "gas pedal" for cell growth and division. In CLOVES syndrome, the mutated protein is stuck in the "on" position, causing cells to grow and multiply uncontrollably. This overactive signaling pathway results in the hallmark features of the syndrome, which include:

Congenital Lipomatous Overgrowth
    Vascular malformations
    Epidermal nevi
    Spinal/skeletal anomalies

Are there environmental triggers for CLOVES syndrome?
Currently, there is no evidence that environmental factors, toxins, or parental lifestyle choices contribute to the development of CLOVES syndrome. The mutation occurs by chance after fertilization. It is important for caregivers to know that nothing done during pregnancy causes the disease, and it cannot be prevented by any known external intervention.

What is the current state of research into the etiology?
Medical researchers are actively investigating targeted therapies, such as PI3K inhibitors, to "throttle back" the overactive signaling pathway that drives CLOVES syndrome. Ongoing studies focus on better understanding the mosaic distribution of the mutation and how it influences the severity of vascular and skeletal overgrowth.

Next steps

Consult with a geneticist to confirm the diagnosis via targeted tissue biopsy or specialized genetic testing.
    Connect with the 7 members of the DiseaseMaps.org community who have shared their experiences with CLOVES syndrome.
    Discuss potential clinical trials involving PI3K-pathway inhibitors with your specialist physician.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome.
    Orphanet: PIK3CA-related overgrowth spectrum (PROS).
    OMIM (Online Mendelian Inheritance in Man): Entry #612918.
    The CLOVES Syndrome Community: Patient-led research and support resources.

Question 19

Does Cloves Syndrome have a cure?

Accepted Answer

Currently, there is no curative treatment for CLOVES syndrome, a rare overgrowth condition caused by somatic mutations in the PIK3CA gene. While a cure does not exist, clinical management focuses on multidisciplinary care to mitigate symptoms, improve quality of life, and address the specific vascular and tissue overgrowth patterns characteristic of CLOVES syndrome.

What is the current approach to managing CLOVES syndrome?
Because CLOVES syndrome involves complex vascular malformations, spinal abnormalities, and lipomatous overgrowth, treatment is symptomatic rather than curative. Medical teams, including pediatric surgeons, dermatologists, and geneticists, work to manage complications such as pain, recurrent infections, and functional limitations. The goal is to provide stability and prevent further progression of the overgrowth.

How is precision medicine changing treatment for CLOVES syndrome?
The landscape of CLOVES syndrome research has shifted significantly toward targeted therapies. Since the discovery that the PIK3CA gene mutation drives the disease, researchers have focused on PI3K inhibitors. These drugs are designed to interfere with the overactive signaling pathways that cause tissue overgrowth. Current efforts include:

Alpelisib: This PI3K inhibitor has shown promise in reducing the volume of vascular malformations and improving symptoms in some patients with CLOVES syndrome.
    Clinical Trials: Ongoing studies are evaluating the long-term safety and efficacy of these inhibitors in pediatric and adult populations.
    Surgical Intervention: Debulking surgeries and sclerotherapy remain essential tools for managing specific anatomical challenges.

What does the future hold for CLOVES syndrome research?
While we are not at a stage where we can "repair" the mutation in every affected cell, researchers are optimistic about the potential for precision medicine. The focus is currently on refining dosing for inhibitors and understanding the long-term impacts of these therapies. Breakthroughs in gene editing and selective delivery systems are in early-stage research, though clinical application remains years away.

Next steps

Consult with a specialist at a center of excellence for vascular anomalies to discuss current treatment options.
    Connect with the 7 members of the DiseaseMaps.org community living with CLOVES syndrome to share experiences and coping strategies.
    Monitor ClinicalTrials.gov for active trials investigating PI3K inhibitors and related targeted therapies.
    Join patient advocacy groups to stay updated on the latest research developments and funding initiatives.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your physician for personalized clinical guidance.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
    Orphanet: Rare disease database for CLOVES syndrome (ORPHA:247605).
    OMIM (Online Mendelian Inheritance in Man): PIK3CA-related overgrowth spectrum (PROS).
    The CLOVES Syndrome Community: Patient-led research and advocacy resources.

Question 20

Cloves Syndrome prognosis

Accepted Answer

CLOVES syndrome is a rare overgrowth disorder caused by somatic PIK3CA mutations, and while there is no cure, the prognosis has significantly improved with the emergence of targeted PI3K inhibitor therapies. Long-term outcomes for those with CLOVES syndrome vary widely depending on the severity of vascular malformations and the extent of tissue overgrowth, but proactive, multidisciplinary care allows many individuals to achieve a good quality of life.

What determines the long-term prognosis for CLOVES syndrome?
The prognosis for CLOVES syndrome depends heavily on the specific manifestations present, such as the size and location of lipomatous masses, the severity of scoliosis, and the nature of vascular anomalies. Because CLOVES syndrome is a mosaic condition, the clinical presentation is highly variable; some individuals experience mild symptoms, while others face significant mobility challenges or chronic pain. Early intervention is the most critical factor in improving long-term outcomes.

How has modern medicine changed outcomes for CLOVES syndrome?
In the past, management of CLOVES syndrome was largely limited to orthopedic surgery and debulking procedures, which often carried high risks of recurrence. Today, the introduction of PI3K inhibitors, such as alpelisib, has revolutionized the management of CLOVES syndrome. These medications target the underlying genetic pathway, often leading to a reduction in the size of vascular malformations and fatty overgrowth, thereby reducing the need for invasive surgeries.

What complications should patients with CLOVES syndrome monitor?
Due to the complex nature of the disorder, individuals with CLOVES syndrome require vigilant monitoring for several potential complications:

Progressive spinal deformities such as scoliosis or kyphosis.
    Deep vein thrombosis (DVT) and pulmonary embolism risks linked to vascular malformations.
    Chronic pain management due to nerve compression or tissue overgrowth.
    Coagulopathy issues related to complex vascular anomalies.
    Developmental delays or seizures, which occur in a subset of patients with brain involvement.

Next steps

Consult a specialized multidisciplinary team, typically including a geneticist, pediatric surgeon, and hematologist.
    Join the 7 members of the DiseaseMaps.org community to share experiences and coping strategies.
    Discuss targeted PI3K inhibitor therapy with your specialist to see if you are a candidate.
    Ensure regular screening for orthopedic and vascular progression to address issues before they become acute.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
    Orphanet: Rare disease database entry for CLOVES syndrome (ORPHA:261245).
    OMIM (Online Mendelian Inheritance in Man): Entry #612918 regarding PIK3CA-related overgrowth spectrum.
    The CLOVES Syndrome Community: Patient-led resources and clinical research updates.

Question 21

What is Cloves Syndrome

Accepted Answer

CLOVES syndrome is a rare overgrowth disorder characterized by congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal/skeletal anomalies. It is caused by somatic mutations in the PIK3CA gene, leading to excessive cell growth and tissue development that typically manifests at or shortly after birth.

What are the primary symptoms of CLOVES syndrome?
CLOVES syndrome is an acronym that describes the core features of the condition. Patients often experience a combination of symptoms involving multiple body systems, including:

Congenital Lipomatous Overgrowth: Fatty tissue masses that are present at birth or early infancy.
    Vascular malformations: Abnormal connections of blood vessels, such as capillary, venous, or lymphatic malformations.
    Epidermal nevi: Skin lesions that may appear as raised, darkened, or velvety patches.
    Spinal/skeletal anomalies: Scoliosis, wide feet, or abnormal bone growth in the limbs.

What causes CLOVES syndrome?
CLOVES syndrome is caused by a somatic activating mutation in the PIK3CA gene. Unlike inherited genetic conditions, these mutations occur after conception (post-zygotic), meaning they are not passed down from parents. This mutation leads to overactivation of the PI3K/AKT/mTOR signaling pathway, which acts like an "accelerator" for cell division and growth, resulting in the characteristic tissue overgrowth seen in CLOVES syndrome patients.

How rare is CLOVES syndrome?
CLOVES syndrome is an extremely rare disorder, with exact prevalence numbers difficult to determine due to historical underdiagnosis. It affects both males and females equally, with no known geographic or ethnic predilection. Currently, our DiseaseMaps.org community includes 7 individuals who have shared their experiences living with CLOVES syndrome, highlighting the importance of global collaboration in understanding this rare condition.

How is CLOVES syndrome different from other overgrowth disorders?
CLOVES syndrome is frequently compared to other PIK3CA-related overgrowth spectrum (PROS) conditions. It is specifically distinguished from conditions like Klippel-Trénaunay syndrome by the presence of specific spinal anomalies and the distinct pattern of lipomatous overgrowth. A clinical geneticist can help differentiate CLOVES syndrome from other syndromes through targeted genetic testing and physical evaluation.

Next steps

Consult with a geneticist or a specialist in vascular anomalies to confirm a diagnosis of CLOVES syndrome.
    Connect with the DiseaseMaps.org community to share experiences with others managing CLOVES syndrome.
    Monitor for new symptoms through a multidisciplinary care team, including orthopedists, dermatologists, and vascular specialists.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding any medical condition.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
    Orphanet: Rare disease database entry for CLOVES syndrome.
    OMIM (Online Mendelian Inheritance in Man): Entry #612918 regarding PIK3CA-related overgrowth.
    The CLOVES Syndrome Community: Patient-led advocacy and research resources.

Question 22

Cloves Syndrome synonyms

Accepted Answer

CLOVES syndrome is an acronym standing for Congenital Lipomatous Overgrowth, Vascular malformations, Epidermal nevi, and Spinal/Skeletal anomalies. While sometimes referred to as CLOVE syndrome (without the final 'S'), medical professionals now standardize the name as CLOVES syndrome to reflect the essential inclusion of spinal and skeletal anomalies.

Why does CLOVES syndrome have multiple names?
The naming of CLOVES syndrome has evolved as researchers better understood its clinical presentation. Originally, the condition was often grouped under the broader umbrella of Proteus syndrome or Klippel-Trénaunay syndrome due to overlapping features. However, the discovery that CLOVES syndrome is caused by specific somatic activating mutations in the PIK3CA gene led to its recognition as a distinct clinical entity. You may still find older medical literature or international case reports using outdated terminology, which can create confusion for families seeking accurate records.

What are the official classifications for CLOVES syndrome?
In medical databases, CLOVES syndrome is categorized under the umbrella of PIK3CA-Related Overgrowth Spectrum (PROS). Standardized identifiers help clinicians and researchers track the condition globally:

Orphanet: ORPHA:261248
    OMIM: #612918
    ICD-10/11: Often coded under "Other specified congenital malformations" or "Overgrowth syndromes" due to its rare status.

Which name should patients use when communicating with doctors?
The medical community currently prefers the term CLOVES syndrome. Using this specific name is crucial because it helps doctors differentiate the condition from other vascular or overgrowth disorders. At DiseaseMaps.org, 7 community members have shared their experiences with CLOVES syndrome, noting that using the full acronym helps ensure they are referred to the correct specialists, such as vascular surgeons, geneticists, or pediatric oncologists familiar with PROS.

Next steps

Confirm your diagnosis with a clinical geneticist who can test for PIK3CA mutations.
    Use the term CLOVES syndrome when searching medical databases like PubMed or NIH GARD to avoid outdated or incorrect information.
    Connect with the DiseaseMaps.org community to learn how others navigate the complexities of this diagnosis.
    Consult with a multidisciplinary team at a center of excellence specializing in vascular anomalies.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with a qualified healthcare professional regarding your specific diagnosis.

References

NIH GARD: CLOVES syndrome (Genetic and Rare Diseases Information Center)
    Orphanet: CLOVES syndrome (ORPHA:261248)
    OMIM: #612918 (Online Mendelian Inheritance in Man)
    PubMed: Literature on PIK3CA-Related Overgrowth Spectrum (PROS)

Question 23

What are the latest advances in Cloves Syndrome?

Accepted Answer

CLOVES syndrome is a rare overgrowth disorder caused by somatic activating mutations in the PIK3CA gene, leading to complex vascular malformations and tissue overgrowth. The most significant advancement in recent years is the transition from symptomatic management to precision medicine using PI3K inhibitors, which target the underlying molecular pathway of CLOVES syndrome.

What is the current state of precision medicine for CLOVES syndrome?
The primary research focus for CLOVES syndrome involves the use of PI3K alpha inhibitors, such as alpelisib. By targeting the overactive PI3K/AKT/mTOR signaling pathway, these therapies aim to reduce the size of vascular malformations and slow the progression of tissue overgrowth. While not a cure, these targeted treatments represent a major paradigm shift in how we manage CLOVES syndrome symptoms.

What are the key research milestones for CLOVES syndrome?
Research into CLOVES syndrome has evolved rapidly, moving from basic genetic discovery to targeted clinical intervention. Key areas of focus include:

Molecular Diagnosis: The shift toward identifying somatic PIK3CA mutations via deep sequencing of affected tissue rather than blood samples.
    PI3K Inhibitor Trials: Multi-center studies investigating the efficacy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS), which includes CLOVES syndrome.
    Natural History Studies: Ongoing efforts to map the long-term clinical trajectory of CLOVES syndrome to better inform surgical and medical interventions.

How can patients get involved in clinical research?
Participation in research is vital for understanding CLOVES syndrome. Patients should engage with the following resources to stay updated on trial opportunities:

Monitor ClinicalTrials.gov by searching specifically for "PIK3CA" or "CLOVES syndrome."
    Connect with the CLOVES Syndrome Community to access patient registries and support networks.
    Consult with specialized centers, such as those within the NIH Undiagnosed Diseases Program or pediatric genetics departments at major academic hospitals.

Next steps

Consult with a geneticist or a specialist in vascular anomalies to discuss current treatment options.
    Join the DiseaseMaps.org community to connect with other families navigating CLOVES syndrome.
    Review active clinical trials on ClinicalTrials.gov and discuss eligibility with your primary care team.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding your specific condition.

References

National Institutes of Health (NIH) GARD: CLOVES Syndrome information page.
    Orphanet: Rare disease database entry for CLOVES syndrome.
    OMIM (Online Mendelian Inheritance in Man): Clinical synopsis for PIK3CA-related disorders.
    CLOVES Syndrome Community: Patient-led advocacy and research support resources.

Question 24

Is it easy to find a partner and/or maintain relationship when you have Cloves Syndrome?

Accepted Answer

CLOVES syndrome is a rare overgrowth disorder that presents unique challenges for intimacy and relationships, but it does not preclude a fulfilling romantic life. While the physical manifestations of CLOVES syndrome may impact body image and sexual comfort, open communication and mutual understanding remain the cornerstones of maintaining healthy, long-term partnerships.

How does CLOVES syndrome affect romantic relationships?
The visible physical differences and the chronic pain associated with CLOVES syndrome can influence self-esteem and body image. In any relationship, it is vital to acknowledge these feelings. Partners of individuals with CLOVES syndrome often navigate the complexities of providing physical assistance, which can shift the relationship dynamic from purely romantic to a mix of caregiving and partnership. Balancing these roles is essential for sustaining long-term emotional and sexual intimacy.

How can I communicate about CLOVES syndrome with a partner?
Honest communication is the most effective way to build trust when living with CLOVES syndrome. Early conversations allow you to set expectations regarding your physical limitations, pain levels, and any specific support you may need. Discussing your needs clearly helps partners understand that your condition is a part of your life, not the entirety of your identity.

What are the considerations for sexual health and intimacy?
Intimacy with CLOVES syndrome requires sensitivity to physical comfort and the potential for fatigue. Strategies for maintaining a healthy sex life include:

Planning: Scheduling intimacy when pain levels are lower or energy is higher.
Positioning: Using pillows or adaptive supports to accommodate physical overgrowth or mobility restrictions.
Communication: Proactively discussing what types of touch are comfortable and what might exacerbate pain.
Pacing: Recognizing that the unpredictability of CLOVES syndrome symptoms may require flexible intimacy plans.

Is CLOVES syndrome hereditary and how does it affect family planning?
CLOVES syndrome is caused by a somatic mutation in the PIK3CA gene, meaning it is not inherited from parents and there is no risk of passing it to children. However, individuals considering family planning should consult with a genetic counselor to confirm the sporadic nature of their specific diagnosis and discuss the logistics of pregnancy if the condition affects the pelvic or abdominal region.

Next steps

Consult a therapist specializing in chronic illness to navigate body image and relationship dynamics.
Connect with the 7 members of the DiseaseMaps.org community living with CLOVES syndrome for peer support.
Consider couples counseling if the strain of caregiving begins to overshadow the romantic connection.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.

References

NIH Genetic and Rare Diseases Information Center (GARD): CLOVES syndrome overview.
Orphanet: Rare disease database entry for CLOVES syndrome.
OMIM (Online Mendelian Inheritance in Man): PIK3CA-related overgrowth spectrum.
CLOVES Syndrome Community: Patient support and advocacy resources.

Question 25

Which advice would you give to someone who has just been diagnosed with Cloves Syndrome?

Accepted Answer

CLOVES syndrome is a rare overgrowth disorder caused by somatic activating mutations in the PIK3CA gene, requiring a multidisciplinary approach to manage complex vascular malformations and tissue overgrowth. While an initial diagnosis of CLOVES syndrome is overwhelming, specialized care and connection with community support can significantly improve long-term outcomes and quality of life.

How do I build the right care team for CLOVES syndrome?
Because CLOVES syndrome affects multiple systems—including the skin, skeletal, and vascular structures—you need a "medical home." Start by seeking a center of excellence that specializes in PIK3CA-related overgrowth spectrum (PROS). Your team should ideally include a pediatric or adult geneticist, a vascular interventional radiologist, an orthopedic surgeon, and a dermatologist. Coordinating care through a single lead specialist helps prevent fragmented treatment.

What are the best strategies for managing daily life with CLOVES syndrome?
Managing the daily impact of CLOVES syndrome involves proactive symptom monitoring and energy conservation. Focus on these practical steps:

Monitor growth: Keep a detailed log of vascular malformations and tissue growth to share with your specialists.
    Prioritize comfort: Work with physical or occupational therapists to find adaptive clothing or orthotics that accommodate overgrowth areas.
    Mental health support: Chronic illness can be isolating; seek a psychologist experienced in rare diseases to help process the diagnosis.
    Pain management: Consult with a pain specialist early to address discomfort related to vascular malformations.

Why is joining a patient community like DiseaseMaps.org important?
Connecting with others who have CLOVES syndrome reduces isolation and provides practical, "lived-experience" knowledge. Currently, 7 members within the DiseaseMaps.org community are navigating life with CLOVES syndrome, offering a unique space to share experiences with treatments and daily management tips that you won't find in textbooks.

How can I stay informed about CLOVES syndrome research?
Research into targeted therapies, such as PI3K inhibitors, is rapidly evolving. Stay informed by monitoring clinical trial registries and patient-led foundations. Being an active participant in your care—and potentially in research—empowers you to make informed decisions about emerging treatment options for CLOVES syndrome.

Next steps

Consult a geneticist to confirm your PIK3CA mutation status.
    Connect with the 7 members living with CLOVES syndrome on DiseaseMaps.org.
    Register with the NIH Genetic and Rare Diseases (GARD) Information Center for updates.
    Reach out to the CLOVES Syndrome Community foundation for specific patient advocacy resources.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your primary care physician or a specialist for personalized clinical guidance.

References

NIH Genetic and Rare Diseases (GARD) Information Center: CLOVES syndrome profile.
    Orphanet: Rare disease database for PROS and CLOVES syndrome.
    OMIM (Online Mendelian Inheritance in Man): Clinical synopsis for PIK3CA-related disorders.
    CLOVES Syndrome Community (patient-led advocacy and research support).

Help others answering the top 25 questions of Cloves Syndrome

What is the life expectancy of someone with Cloves Syndrome?

1 answer

Celebrities with Cloves Syndrome

1 answer

Is Cloves Syndrome hereditary?

1 answer

Is Cloves Syndrome contagious?

2 answers

ICD10 code of Cloves Syndrome and ICD9 code

1 answer

Is there any natural treatment for Cloves Syndrome?

1 answer

Living with Cloves Syndrome. How to live with Cloves Syndrome?

1 answer

Cloves Syndrome diet. Is there a diet which improves the quality of life of people with Cloves Syndrome?

1 answer

What is the history of Cloves Syndrome?

1 answer

Is it advisable to do exercise when affected by Cloves Syndrome? Which activities would you suggest and how intense should they be?

1 answer

How is Cloves Syndrome diagnosed?

1 answer

Which are the symptoms of Cloves Syndrome?

1 answer

Can people with Cloves Syndrome work? What kind of work can they perform?

1 answer

How do I know if I have Cloves Syndrome?

1 answer

What are the best treatments for Cloves Syndrome?

1 answer

What is the prevalence of Cloves Syndrome?

1 answer

Cloves Syndrome and depression

1 answer

Which are the causes of Cloves Syndrome?

1 answer

Does Cloves Syndrome have a cure?

1 answer

Cloves Syndrome prognosis

1 answer

What is Cloves Syndrome

1 answer

Cloves Syndrome synonyms

1 answer

What are the latest advances in Cloves Syndrome?

1 answer

Is it easy to find a partner and/or maintain relationship when you have Cloves Syndrome?

1 answer

Which advice would you give to someone who has just been diagnosed with Cloves Syndrome?

1 answer